Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,836
Closed -$2.23M 207
2026
Q1
$2.23M Sell
24,836
-124
-0.5% -$11.9K 0.33% 117
2025
Q4
$2.32M Buy
24,960
+127
+0.5% +$13.8K 0.35% 97
2025
Q3
$3.09M Buy
24,833
+774
+3% +$98.4K 0.49% 71
2025
Q2
$3.17M Buy
24,059
+248
+1% +$28.1K 0.57% 63
2025
Q1
$2.49M Buy
23,811
+1,323
+6% +$139K 0.46% 74
2024
Q4
$2.4M Hold
22,488
0.43% 73
2024
Q3
$2.4M Buy
22,488
+13,942
+163% +$1.41M 0.43% 74
2024
Q2
$846K Buy
8,546
+246
+3% +$24.8K 0.18% 121
2024
Q1
$768K Buy
+8,300
New +$669K 0.16% 131

Other funds holding ITRI

Oliver Luxxe Assets's ITRI Position: Q2 2026 in Review

Oliver Luxxe Assets sold out of Itron (ITRI) in Q2 2026, closing a stake of 24,836 shares — an estimated $2.23M sold.

Oliver Luxxe Assets first reported a position in ITRI in Q1 2024 and held it in 9 quarters. The position peaked at $3.17M in Q2 2025. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Oliver Luxxe Assets reported no remaining Itron position as of Q2 2026 after selling out during the quarter.
  • Oliver Luxxe Assets sold 24,836 Itron shares in Q2 2026, an estimated $2.23M.
  • Oliver Luxxe Assets first reported a position in Itron in Q1 2024 and held it in 9 quarters.
  • Oliver Luxxe Assets's Itron position peaked at $3.17M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.